eli lilly gip glp-1 First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! announced positive topline results from the GLP-1 Dry Mouth, Bad Special-Sugar-Free Months:3 Month

eli lilly gip glp-1 First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & Glucagon triple hormone receptor agonist drug leads to nearly 29% weight loss in first pivotal test! announced positive topline results from the GLP-1 Dry Mouth, Bad Special-Sugar-Free Months:3 Month

GLP-1 Dry Mouth, Bad Breath, & Taste Changes: What Actually Helps?

, George Washington University 30+ years of clinical experience Dr

Special-Sugar-Free

Months:3 Month

Discussing this with biotech/pharma sponsors and building some dose escalation buffer into a protocol to keep the participant in the study and manage these AEs (when possible) can be a good strategy to keep participants in the trial & improve their experience